Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease-Reference-Cited by-同舟云学术

Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease

Published:2022-12-26 Issue: Volume: Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Aguillon David¹,Langella Stephanie²,Chen Yinghua³,Sanchez Justin S.⁴,Su Yi³,Vila‐Castelar Clara²,Vasquez Daniel¹,Zetterberg Henrik⁵⁶⁷⁸⁹,Hansson Oskar¹⁰¹¹,Dage Jeffrey L.¹²,Janelidze Shorena¹⁰,Chen Kewei³,Fox‐Fuller Joshua T.²¹³,Aduen Paula²,Martinez Jairo E.²¹³,Garcia Gloria¹,Baena Ana¹,Guzman Claudia¹,Johnson Keith A.¹⁴⁴,Sperling Reisa A.¹⁴⁴,Blennow Kaj⁵⁶,Reiman Eric M.³,Lopera Francisco¹,Quiroz Yakeel T.¹²⁴

Affiliation:

1. Grupo de Neurociencias de Antioquia, Facultad de Medicina Universidad de Antioquia Medellin Colombia

2. Department of Psychiatry, Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA

3. Banner Alzheimer's Institute Phoenix Arizona USA

4. Department of Neurology, Massachusetts General Hospital Harvard Medical School Boston Massachusetts United States

5. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology the Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden

6. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

7. Department of Neurodegenerative Disease, UCL Institute of Neurology Queen Square London UK

8. UK Dementia Research Institute at UCL London UK

9. Hong Kong Center for Neurodegenerative Diseases Hong Kong China

10. Memory Clinic Skåne University Hospital Malmö Sweden

11. Clinical Memory Research Unit, Department of Clinical Sciences Malmö Lund University Lund Sweden

12. Indiana University School of Medicine Indianapolis Indiana USA

13. Department of Psychological and Brain Sciences Boston University Boston Massachusetts USA

14. Department of Neurology, Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12906

Reference43 articles.

1. Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment

2. Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis

3. Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease

4. P-tau217 in Alzheimer’s disease

5. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma p-tau217 in Alzheimer’s disease: Lumipulse and ALZpath SIMOA head-to-head comparison;2024-05-03

2. Insights into the progression of genetic Alzheimer's disease from tau PET;The Lancet Neurology;2024-05

3. Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects;Journal of Alzheimer's Disease;2024-04-02

4. A critical appraisal of blood-based biomarkers for Alzheimer’s disease;Ageing Research Reviews;2024-04

5. Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease;International Journal of Molecular Sciences;2024-01-19